R01HG011927
Project Grant
Overview
Grant Description
Choices for Sickle Cell Reproductive Health: RCT of a Preconception Intervention Model for a Single Gene Disorder - Project Summary/Abstract
Our long-term goal is to foster genetically-informed reproductive health knowledge and behaviors among young adults with Sickle Cell Disease (SCD) or Sickle Cell Trait (SCT) with a web-based, tailored, multimedia intervention (Choices). In follow-up to genetic counseling, Choices helps them engage in behaviors concordant with their parenting plan.
Developed with the Sickle Cell community, Choices is designed to help young adults with SCD or SCT gain knowledge of genetic inheritance, specify their preconception reproductive health intentions (their parenting plan), and engage in reproductive health behaviors concordant with their parenting plan.
We found high acceptability of both the e-book (usual care control) and Choices interventions. We also found sustained (24 months), significant effects on knowledge but not on behavior, presumably because 49% of the participants were not at risk of having a child with SCD (e.g., partner had normal hemoglobin, HGB A).
Of the participants at risk of having a child with SCD (at-risk) and who expressed intention to get pregnant soon and have a child free of SCD, the Choices group's (N=26) behaviors showed a 27% relative at-risk time reduction compared to the e-book group (N=16). However, the difference was not statistically significant given the small, underpowered sample (N=42).
Hence, we propose an adequately powered RCT with the Choices intervention and an e-book control to compare their effects on genetic inheritance knowledge and at-risk reproductive health behaviors (immediate posttest and at 6, 12, 18, & 24 months). Using proven strategies (referrals, social media, and communication technology) for recruiting and retaining the sample, we will use web-based data collection (SCKNOWIQ) and intervention delivery strategies enhanced by nudges and tailored boosters.
In a sample of 430 adult men and women, aged 18-35 years with SCD or SCT, at-risk, and planning within 2 years to have a child free of SCD, the specific aims are to:
Aim 1. Compare e-book and Choices groups for effects on (a) knowledge (primary endpoint), and (b) at-risk behavior (secondary endpoint) measured with the SCKNOWIQ over time (baseline, post-test, 6, 12, 18, 24 months). We hypothesize that across all time points post baseline, there will be (a) higher knowledge scores and (b) lower percentage of time with at-risk behaviors (at-risk time) in the Choices than in the e-book groups.
Aim 2. Explore the relationship between demographic factors (e.g., sex, SC status), intervention acceptability, and the Aim 1 endpoints (knowledge, behavior). We will conduct subgroup analyses to provide insight into the baseline knowledge and behavior as well as the intervention effects in different demographic or acceptability groups.
Given the scalability and low cost of Choices, if proved to be effective, it can reach the affected population at low cost. As a genetic counseling follow-up model, Choices may translate into informed parental decisions and preparedness for the consequences of their preconception decisions. Considering the implications for SCD and other single-gene diseases globally, the potential impact is enormous.
Our long-term goal is to foster genetically-informed reproductive health knowledge and behaviors among young adults with Sickle Cell Disease (SCD) or Sickle Cell Trait (SCT) with a web-based, tailored, multimedia intervention (Choices). In follow-up to genetic counseling, Choices helps them engage in behaviors concordant with their parenting plan.
Developed with the Sickle Cell community, Choices is designed to help young adults with SCD or SCT gain knowledge of genetic inheritance, specify their preconception reproductive health intentions (their parenting plan), and engage in reproductive health behaviors concordant with their parenting plan.
We found high acceptability of both the e-book (usual care control) and Choices interventions. We also found sustained (24 months), significant effects on knowledge but not on behavior, presumably because 49% of the participants were not at risk of having a child with SCD (e.g., partner had normal hemoglobin, HGB A).
Of the participants at risk of having a child with SCD (at-risk) and who expressed intention to get pregnant soon and have a child free of SCD, the Choices group's (N=26) behaviors showed a 27% relative at-risk time reduction compared to the e-book group (N=16). However, the difference was not statistically significant given the small, underpowered sample (N=42).
Hence, we propose an adequately powered RCT with the Choices intervention and an e-book control to compare their effects on genetic inheritance knowledge and at-risk reproductive health behaviors (immediate posttest and at 6, 12, 18, & 24 months). Using proven strategies (referrals, social media, and communication technology) for recruiting and retaining the sample, we will use web-based data collection (SCKNOWIQ) and intervention delivery strategies enhanced by nudges and tailored boosters.
In a sample of 430 adult men and women, aged 18-35 years with SCD or SCT, at-risk, and planning within 2 years to have a child free of SCD, the specific aims are to:
Aim 1. Compare e-book and Choices groups for effects on (a) knowledge (primary endpoint), and (b) at-risk behavior (secondary endpoint) measured with the SCKNOWIQ over time (baseline, post-test, 6, 12, 18, 24 months). We hypothesize that across all time points post baseline, there will be (a) higher knowledge scores and (b) lower percentage of time with at-risk behaviors (at-risk time) in the Choices than in the e-book groups.
Aim 2. Explore the relationship between demographic factors (e.g., sex, SC status), intervention acceptability, and the Aim 1 endpoints (knowledge, behavior). We will conduct subgroup analyses to provide insight into the baseline knowledge and behavior as well as the intervention effects in different demographic or acceptability groups.
Given the scalability and low cost of Choices, if proved to be effective, it can reach the affected population at low cost. As a genetic counseling follow-up model, Choices may translate into informed parental decisions and preparedness for the consequences of their preconception decisions. Considering the implications for SCD and other single-gene diseases globally, the potential impact is enormous.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Gainesville,
Florida
326115500
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 298% from $762,494 to $3,034,701.
University Of Florida was awarded
Genetically-Informed Reproductive Health Intervention Sickle Cell: RCT Study
Project Grant R01HG011927
worth $3,034,701
from National Human Genome Research Institute in September 2021 with work to be completed primarily in Gainesville Florida United States.
The grant
has a duration of 3 years 9 months and
was awarded through assistance program 93.172 Human Genome Research.
The Project Grant was awarded through grant opportunity Investigator-Initiated Research on Genetic Counseling Processes and Practices (R01, Clinical Trial Optional).
Status
(Complete)
Last Modified 7/19/24
Period of Performance
9/1/21
Start Date
6/30/25
End Date
Funding Split
$3.0M
Federal Obligation
$0.0
Non-Federal Obligation
$3.0M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for R01HG011927
Transaction History
Modifications to R01HG011927
Additional Detail
Award ID FAIN
R01HG011927
SAI Number
R01HG011927-868617407
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75N400 NIH NATIONAL HUMAN GENOME RESEARCH INSTITUTE
Funding Office
75N400 NIH NATIONAL HUMAN GENOME RESEARCH INSTITUTE
Awardee UEI
NNFQH1JAPEP3
Awardee CAGE
5E687
Performance District
FL-03
Senators
Marco Rubio
Rick Scott
Rick Scott
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Human Genome Research Institute, National Institutes of Health, Health and Human Services (075-0891) | Health research and training | Grants, subsidies, and contributions (41.0) | $1,524,970 | 100% |
Modified: 7/19/24